162 related articles for article (PubMed ID: 36471278)
21. High Expression of Asparagine Synthetase Is Associated with Poor Prognosis of Breast Cancer in Chinese Population.
Qin C; Yang X; Zhan Z
Cancer Biother Radiopharm; 2020 Oct; 35(8):581-585. PubMed ID: 32412789
[No Abstract] [Full Text] [Related]
22. PER3 plays anticancer roles in the oncogenesis and progression of breast cancer via regulating MEK/ERK signaling pathway.
Liu Y; Wu Z; Li Y; Zhang J; Gao Y; Yuan G; Han M
J Chin Med Assoc; 2022 Nov; 85(11):1051-1060. PubMed ID: 36278918
[TBL] [Abstract][Full Text] [Related]
23. B7 homolog 3 induces lung metastasis of breast cancer through Raf/MEK/ERK axis.
Wang S; Zhang X; Ning H; Dong S; Wang G; Sun R
Breast Cancer Res Treat; 2022 Jun; 193(2):405-416. PubMed ID: 35312883
[TBL] [Abstract][Full Text] [Related]
24. Transglutaminase 2 Binds to the CD44v6 Cytoplasmic Domain to Stimulate CD44v6/ERK1/2 Signaling and Maintain an Aggressive Cancer Phenotype.
Chen X; Adhikary G; Newland JJ; Xu W; Keillor JW; Weber DJ; Eckert RL
Mol Cancer Res; 2023 Sep; 21(9):922-932. PubMed ID: 37227250
[TBL] [Abstract][Full Text] [Related]
25. Osteoprotegerin promotes the proliferation of chondrocytes and affects the expression of ADAMTS-5 and TIMP-4 through MEK/ERK signaling.
Feng ZY; He ZN; Zhang B; Chen Z
Mol Med Rep; 2013 Dec; 8(6):1669-79. PubMed ID: 24126801
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of pyruvate dehydrogenase E1A and its inactive phosphorylated form among breast cancer subtypes.
Zaher DM; Talaat IM; Hussein A; Hachim MY; Omar HA
Life Sci; 2021 Nov; 284():119885. PubMed ID: 34384830
[TBL] [Abstract][Full Text] [Related]
27. S-Nitrosylation of Tissue Transglutaminase in Modulating Glycolysis, Oxidative Stress, and Inflammatory Responses in Normal and Indoxyl-Sulfate-Induced Endothelial Cells.
Lin CJ; Chiu CY; Liao EC; Wu CJ; Chung CH; Greenberg CS; Lai TS
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446114
[TBL] [Abstract][Full Text] [Related]
28. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
[TBL] [Abstract][Full Text] [Related]
29. PDRG1 promotes the proliferation and migration of GBM cells by the MEK/ERK/CD44 pathway.
Sun J; Xu Y; Liu J; Cui H; Cao H; Ren J
Cancer Sci; 2022 Feb; 113(2):500-516. PubMed ID: 34812552
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Value of Combined Lactate Dehydrogenase, C-Reactive Protein, Cancer Antigen 153 and Cancer Antigen 125 in Metastatic Breast Cancer.
Ma YY; Wang H; Zhao WD; Li YF; Wang JJ; Chen XY; Huang YQ; Wang WJ; Wang Y; Sun SC
Cancer Control; 2022; 29():10732748211053150. PubMed ID: 34989251
[TBL] [Abstract][Full Text] [Related]
31. PI3K/Akt-sensitive MEK-independent compensatory circuit of ERK activation in ER-positive PI3K-mutant T47D breast cancer cells.
Aksamitiene E; Kholodenko BN; Kolch W; Hoek JB; Kiyatkin A
Cell Signal; 2010 Sep; 22(9):1369-78. PubMed ID: 20471474
[TBL] [Abstract][Full Text] [Related]
32. Insulin promotes proliferation, survival, and invasion in endometrial carcinoma by activating the MEK/ERK pathway.
Wang Y; Zhu Y; Zhang L; Tian W; Hua S; Zhao J; Zhang H; Xue F
Cancer Lett; 2012 Sep; 322(2):223-31. PubMed ID: 22459351
[TBL] [Abstract][Full Text] [Related]
33. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
34. Prognostic and therapeutic relevance of phosphofructokinase platelet-type (PFKP) in breast cancer.
Umar SM; Kashyap A; Kahol S; Mathur SR; Gogia A; Deo SVS; Prasad CP
Exp Cell Res; 2020 Nov; 396(1):112282. PubMed ID: 32919954
[TBL] [Abstract][Full Text] [Related]
35. Sulforaphane covalently interacts with the transglutaminase 2 cancer maintenance protein to alter its structure and suppress its activity.
Rorke EA; Adhikary G; Szmacinski H; Lakowicz JR; Weber DJ; Godoy-Ruiz R; Puranik P; Keillor JW; Gates EWJ; Eckert RL
Mol Carcinog; 2022 Jan; 61(1):19-32. PubMed ID: 34610184
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of phosphorylated MEK and ERK correlates with aggressive BCC subtypes.
Rahman MM; Herath D; Bladen JC; Atkar R; Pirzado MS; Harwood C; Philpott MP; Neill GW
Carcinogenesis; 2021 Jul; 42(7):975-983. PubMed ID: 34003214
[TBL] [Abstract][Full Text] [Related]
37. Long non‑coding RNA BANCR promotes proliferation, invasion and migration in esophageal squamous cell carcinoma cells via the Raf/MEK/ERK signaling pathway.
Yu X; Huang M; Yang G
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880577
[TBL] [Abstract][Full Text] [Related]
38. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
Miranda MB; McGuire TF; Johnson DE
Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
[TBL] [Abstract][Full Text] [Related]
39. HOXA3 promotes tumor growth of human colon cancer through activating EGFR/Ras/Raf/MEK/ERK signaling pathway.
Zhang X; Liu G; Ding L; Jiang T; Shao S; Gao Y; Lu Y
J Cell Biochem; 2018 Mar; 119(3):2864-2874. PubMed ID: 29073728
[TBL] [Abstract][Full Text] [Related]
40. Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer.
Yao J; Jin Q; Wang XD; Zhu HJ; Ni QC
Medicine (Baltimore); 2017 Jun; 96(25):e7171. PubMed ID: 28640095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
